Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib with Paclitaxel and Carboplatin in Uterine Carcinosarcoma
NCT00687687Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of iniparib in uterine carcinosarcoma (UCS), sponsored by Sanofi. Primary endpoint: Clinical response rate at 6 months. Started May 2008; status: completed.
02
Drugs
iniparib
03
Conditions
uterine carcinosarcoma (UCS)
Beyond the preview
Go deeper on NCT00687687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687687.